Brett Sandercock - Jan 8, 2025 Form 4 Insider Report for RESMED INC (RMD)

Signature
Brett Sandercock, Chief Financial Officer
Stock symbol
RMD
Transactions as of
Jan 8, 2025
Transactions value $
-$234,040
Form type
4
Date filed
1/10/2025, 04:52 PM
Previous filing
Dec 11, 2024
Next filing
Feb 11, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$234K -1K -1.07% $234.04 92.9K Jan 8, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted February 6, 2024.